Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-17-009882
Filing Date
2017-09-21
Accepted
2017-09-21 10:48:39
Documents
1
Period of Report
2017-09-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3091117essetifin_fennec.html 3  
1 OWNERSHIP DOCUMENT f3091117essetifin_fennec.xml 3 2652
  Complete submission text file 0001213900-17-009882.txt   4500
Mailing Address VIA SUDAFRICA 20 ROME L6 00144
Business Address
Essetifin SPA (Reporting) CIK: 0001092601 (see all company filings)

Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-32295 | Film No.: 171095256

Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)